Patents/Assignees

Hibercell, Inc.

8 patents in portfolio

US12473296utility2025
Perk Inhibiting Compounds
0 cites
US12390526utility2025
Methods for Identifying Beta-glucan Binding to Immune Cells
0 cites
US12331054utility2025
Perk Inhibiting Imidazolopyrazine Compounds
0 cites
US12006332utility2024
Aminopyrimidine Derivatives as Phosphatidylinositol Phosphate Kinase Inhibitors
0 cites
US11919902utility2024
Aryl-bipyridine Amine Derivatives as Phosphatidylinositol Phosphate Kinase Inhibitors
0 cites
US11815435utility2023
Beta Glucan Immunopharmacodynamics
0 cites
US11667651utility2023
Aminopyridine Derivatives as Phosphatidylinositol Phosphate Kinase Inhibitors
0 cites
US11584763utility2023
Chromenopyridine Derivatives as Phosphatidylinositol Phosphate Kinase Inhibitors
0 cites